A Case of Diabetic Ketoacidosis Induced by Sodium-Glucose Cotransporter 2 Inhibitor / 임상당뇨병
Journal of Korean Diabetes
;
: 310-314, 2015.
Article
in Korean
| WPRIM
| ID: wpr-726846
ABSTRACT
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a new class of oral antihyperglycemic drugs; inhibition of the cotransporter allows for increased renal glucose excretion that consequently leads to reduced plasma glucose level. We report a rare case of a 73-year-old woman with type 2 diabetes mellitus who developed severe ketoacidosis caused by an SGLT2 inhibitor. At admission, severe ketoacidosis with arterial PH 6.99 was observed, though her serum glucose level of 232 mg/dL was not excessively high. It is necessary to pay attention to patients with type 2 diabetes being treated with an SGLT2 inhibitor, as anorexia, diarrhea, dehydration, and weight loss can develop in conjunction with a high fat/protein diet.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Blood Glucose
/
Weight Loss
/
Anorexia
/
Diabetic Ketoacidosis
/
Dehydration
/
Diabetes Mellitus
/
Diabetes Mellitus, Type 2
/
Diarrhea
/
Diet
/
Glucose
Limits:
Aged
/
Female
/
Humans
Language:
Korean
Journal:
Journal of Korean Diabetes
Year:
2015
Type:
Article
Similar
MEDLINE
...
LILACS
LIS